Navigation Links
Depomed Reports Second Quarter 2014 Financial Results
Date:8/6/2014

inancial Outlook Depomed is increasing its guidance for total revenues and GAAP earnings per share  for full year 2014 and is reiterating its guidance for product sales, non-GAAP adjusted earnings per share and cash flow for  full year 2014:

  • Product sales of approximately $115 to $125 million
  • Total revenues of approximately $215 to $230 million, which includes non-cash revenues related to the PDL transaction and $15 million in milestones already received in 2014 from Mallinckrodt
  • GAAP earnings per share of approximately $0.36 to $0.51 per share, which includes the non-cash PDL revenues and non-cash PDL interest expense
  • Non-GAAP adjusted earnings per share of break-even to $0.16 per share
  • Cash flow of at least break-even excluding payment of approximately $58 million in taxes in the first quarter of 2014 related to fiscal year 2013
  • The increases in guidance regarding total revenues and GAAP earnings per share are entirely due to increased estimates of non-cash PDL royalty revenues resulting from net sales of Glumetza by Salix Pharmaceuticals during the first half of 2014.

    Non-GAAP Financial MeasuresIn this press release, Depomed includes information about non-GAAP adjusted earnings per share, a non-GAAP financial measure, as a useful operating metric for the three and six month periods ended June 30, 2014 and its 2014 financial outlook. The Company believes that the presentation of this non-GAAP financial measure, when viewed with our results and projections under GAAP and the accompanying reconciliation, provides supplementary information to investors. The Company uses this non-GAAP measure in connection with its own planning and forecasting purposes and for measuring the Company's performance. This non-GAAP financial measure should be considered in addition to, and not a substitute for, or superior to, net income or other financial measures calculated in accordance with GAAP. Non-GAAP adjust
    '/>"/>

    SOURCE Depomed, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
    2. Depomed To Present At Jefferies 2012 Global Health Care Conference
    3. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
    4. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
    5. Depomed To Report Second Quarter Fiscal Year 2012 Financial Results On Thursday, August 2, 2012
    6. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
    7. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
    8. Depomed To Present At UBS Global Life Sciences Conference
    9. Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
    10. Depomed Reports Third Quarter Financial Results
    11. Depomed To Present At Lazard 2012 Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
    (Date:12/24/2014)... SCHOFIELD, Wis. , Dec. 23, 2014 ... and marketer of over-the-counter (OTC) medicinal and healthcare products, ... production of MigraPure® H, a hemp-based, advanced headache relief ... marijuana dispensaries in Colorado , ... . With the MigraPure H Advanced ...
    (Date:12/24/2014)... SAN DIEGO , Dec. 23, 2014 ResMed ... a significant patent infringement action against Chinese medical device manufacturer ... Commission (ITC) ruled today that BMC,s masks listed below infringe ... advertising, or selling these masks in the United ... , iVolve N2 nasal mask , Willow nasal pillows ...
    Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
    ... , JOHANNESBURG, South Africa, Nov. 26 The 2009 ... Award in the Generic Pharmaceutical Market is presented to ... ) , For the Company of the Year Award, ... performance against key competitors: growth strategy and implementation, degree ...
    ... , WESTON, Fla., Nov. 25 American Scientific ... that they have opened a regional marketing and production management office ... location abroad, providing an essential gateway for the development and production ... adults to be distributed and sold globally. Currently the company ...
    Cached Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2
    (Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
    (Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
    (Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
    (Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
    (Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
    Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
    ... Prescribed TherapiesSACRAMENTO, Calif., May 11 The California chapter ... network of over 250 physicians with the shared mission ... treatments and therapies, today cited a recent survey of ... number of physicians believe insurance companies are getting in ...
    ... May 11 Cell Therapeutics, Inc. ("CTI" or the "Company") ... of Directors has authorized a "Modified Dutch Auction" tender offer ... of its common stock, no par value ("Common Stock"), and ... principal amount for the following outstanding shares of the Company,s ...
    ... . , Montreal, May 11, 2009 When ... an equal hand. The latest study by Dr. Maya Saleh, ... and McGill University, shows that women have a more powerful ... by females could have a beneficial effect on the innate ...
    ... The National Organization for Rare Disorders (NORD) will honor ... cutting-edge television network, and several pioneering companies developing treatments ... the National Press Club in Washington, DC, on Thursday, ... which researchers and others are honored for significant achievements ...
    ... Aon Corporation (NYSE: AOC ) Chairman, Lester B. ... 15, 2009 at 10:00 a.m. Central Time. A webcast of ... Chicago will be available via the Internet. This listen-only webcast ... web site at www.aon.com . The webcast ...
    ... 50 percent by the 14th test, study finds, , , MONDAY, ... you undergo, the higher your risk of having at least ... may seem like common sense, it,s not something that patients ... in the May/June issue of the Annals of Family ...
    Cached Medicine News:Health News:Alliance for Patient Access Wants Health Care Code of Conduct 2Health News:Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 2Health News:Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 3Health News:Equality of the sexes? Not always when it comes to biology 2Health News:NORD to Honor Rare Disease Pioneers 2Health News:NORD to Honor Rare Disease Pioneers 3Health News:Aon to Webcast Annual Shareholders' Meeting 2Health News:More Cancer Tests Mean More False-Positive Results 2Health News:More Cancer Tests Mean More False-Positive Results 3
    ... Lyphochek Elevated Immunosuppressant Control is a ... whole blood. This unique product is ideal ... very high Cyclosporine levels, such as C2 ... patients at two hours post-dose., ,Lyphochek Elevated ...
    Liquichek Hematology-16T Control is a hematology reference control used in monitoring determinations of blood cell values on TOA SYSMEX cell counters....
    NEW Liquichek Reticulocyte Control (A)is an assayed whole blood control for evaluating the precision of automated methods of reticulocyte counting....
    Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
    Medicine Products: